Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Epigenetic targeting of DNA repair in lung cancer.

Lok BH, Rudin CM.

Proc Natl Acad Sci U S A. 2019 Nov 5;116(45):22429-22431. doi: 10.1073/pnas.1916581116. Epub 2019 Oct 29. No abstract available.

PMID:
31662477
2.

Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.

Fan D, Ma J, Bell AC, Groen AH, Olsen KS, Lok BH, Leeman JE, Anderson E, Riaz N, McBride S, Ganly I, Shaha AR, Sherman EJ, Tsai CJ, Kang JJ, Lee NY.

Cancer. 2019 Oct 8. doi: 10.1002/cncr.32548. [Epub ahead of print]

PMID:
31593317
3.

Positron-Emission Tomographic Imaging of a Fluorine 18-Radiolabeled Poly(ADP-Ribose) Polymerase 1 Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in SCLC Patient-Derived Xenografts.

Laird J, Lok BH, Carney B, Kossatz S, de Stanchina E, Reiner T, Poirier JT, Rudin CM.

J Thorac Oncol. 2019 Oct;14(10):1743-1752. doi: 10.1016/j.jtho.2019.05.032. Epub 2019 Jun 11.

PMID:
31195178
4.

Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignancies.

Ma J, Laird JH, Chau KW, Chelius MR, Lok BH, Yahalom J.

Cancer Med. 2019 Jan;8(1):58-66. doi: 10.1002/cam4.1844. Epub 2018 Dec 30.

5.

Proton Radiotherapy for Recurrent or Metastatic Head and Neck Cancers with Palliative Quad Shot.

Ma J, Lok BH, Zong J, Gutiontov SI, Cai X, Bell AC, Shcherba M, Xiao H, Sherman EJ, Tsai CJ, Riaz N, McBride SM, Cahlon O, Lee NY.

Int J Part Ther. 2018 Spring;4(4):10-19. doi: 10.14338/IJPT-18-00003.1.

6.

Talazoparib Is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and Xenografts.

Laird JH, Lok BH, Ma J, Bell A, de Stanchina E, Poirier JT, Rudin CM.

Clin Cancer Res. 2018 Oct 15;24(20):5143-5152. doi: 10.1158/1078-0432.CCR-18-0401. Epub 2018 Jun 26.

7.

Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery.

Katsoulakis E, Leeman JE, Lok BH, Shi W, Zhang Z, Tsai JC, McBride SM, Sherman EJ, Cohen M, Wong R, Ganly I, Lee NY, Riaz N.

Laryngoscope. 2018 Nov;128(11):2539-2545. doi: 10.1002/lary.27191. Epub 2018 Apr 10.

8.

Outcome After Radiation Therapy for Langerhans Cell Histiocytosis Is Dependent on Site of Involvement.

Laird J, Ma J, Chau K, Chelius M, Shi W, Zhang Z, Lok BH, Yahalom J.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):670-678. doi: 10.1016/j.ijrobp.2017.10.053. Epub 2017 Nov 6.

9.

Target engagement imaging of PARP inhibitors in small-cell lung cancer.

Carney B, Kossatz S, Lok BH, Schneeberger V, Gangangari KK, Pillarsetty NVK, Weber WA, Rudin CM, Poirier JT, Reiner T.

Nat Commun. 2018 Jan 12;9(1):176. doi: 10.1038/s41467-017-02096-w.

10.

Factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer.

Lok BH, Ma J, Foster A, Perez CA, Shi W, Zhang Z, Li BT, Rudin CM, Rimner A, Wu AJ.

Adv Radiat Oncol. 2017 Aug 8;2(4):548-554. doi: 10.1016/j.adro.2017.08.001. eCollection 2017 Oct-Dec.

11.

Unravelling the biology of SCLC: implications for therapy.

Sabari JK, Lok BH, Laird JH, Poirier JT, Rudin CM.

Nat Rev Clin Oncol. 2017 Sep;14(9):549-561. doi: 10.1038/nrclinonc.2017.71. Epub 2017 May 23. Review.

12.

Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.

Gardner EE, Lok BH, Schneeberger VE, Desmeules P, Miles LA, Arnold PK, Ni A, Khodos I, de Stanchina E, Nguyen T, Sage J, Campbell JE, Ribich S, Rekhtman N, Dowlati A, Massion PP, Rudin CM, Poirier JT.

Cancer Cell. 2017 Feb 13;31(2):286-299. doi: 10.1016/j.ccell.2017.01.006.

13.

Challenges and opportunities in primary CNS lymphoma: A systematic review.

Kerbauy MN, Moraes FY, Lok BH, Ma J, Kerbauy LN, Spratt DE, Santos FP, Perini GF, Berlin A, Chung C, Hamerschlak N, Yahalom J.

Radiother Oncol. 2017 Mar;122(3):352-361. doi: 10.1016/j.radonc.2016.12.033. Epub 2017 Jan 16. Review.

PMID:
28104300
14.

Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM.

Ma J, Setton J, Morris L, Albornoz PB, Barker C, Lok BH, Sherman E, Katabi N, Beal K, Ganly I, Powell SN, Lee N, Chan TA, Riaz N.

Oncotarget. 2017 Feb 7;8(6):10312-10323. doi: 10.18632/oncotarget.14400.

15.

Proton Radiation Therapy for Local Control in a Case of Osteosarcoma of the Neck.

Gutiontov SI, Zumsteg ZS, Lok BH, Berry S, Tsai CJ, McBride SM, Riaz N, Cahlon O, Lee NY.

Int J Part Ther. 2017 Winter;3(3):421-428. doi: 10.14338/IJPT-16-00015.1. Epub 2017 Mar 14.

16.

The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era.

Zumsteg ZS, Lok BH, Ho AS, Drill E, Zhang Z, Riaz N, Shiao SL, Ma J, McBride SM, Tsai CJ, Baxi SS, Sherman EJ, Lee NY.

Cancer. 2017 Apr 15;123(8):1345-1353. doi: 10.1002/cncr.30495. Epub 2016 Dec 16.

17.

High-dose hypofractionated radiotherapy is effective and safe for tumors in the head-and-neck.

Teckie S, Lok BH, Rao S, Gutiontov SI, Yamada Y, Berry SL, Zelefsky MJ, Lee NY.

Oral Oncol. 2016 Sep;60:74-80. doi: 10.1016/j.oraloncology.2016.06.016. Epub 2016 Jul 12.

18.

PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer.

Lok BH, Gardner EE, Schneeberger VE, Ni A, Desmeules P, Rekhtman N, de Stanchina E, Teicher BA, Riaz N, Powell SN, Poirier JT, Rudin CM.

Clin Cancer Res. 2017 Jan 15;23(2):523-535. doi: 10.1158/1078-0432.CCR-16-1040. Epub 2016 Jul 20.

19.

Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers.

Lok BH, Jiang G, Gutiontov S, Lanning RM, Sridhara S, Sherman EJ, Tsai CJ, McBride SM, Riaz N, Lee NY.

Oral Oncol. 2015 Oct;51(10):957-62. doi: 10.1016/j.oraloncology.2015.07.011. Epub 2015 Aug 14.

20.

Irradiation for locoregionally recurrent, never-irradiated oral cavity cancers.

Lok BH, Chin C, Riaz N, Ho F, Hu M, Hong JC, Shi W, Zhang Z, Sherman E, Wong RJ, Morris LG, Ganly I, Wolden SL, Rao SS, Lee NY.

Head Neck. 2015 Nov;37(11):1633-41. doi: 10.1002/hed.23806. Epub 2014 Aug 28.

21.

Constraining the brachial plexus does not compromise regional control in oropharyngeal carcinoma.

Mutter RW, Lok BH, Dutta PR, Riaz N, Setton J, Berry SL, Goenka A, Zhang Z, Rao SS, Wolden SL, Lee NY.

Radiat Oncol. 2013 Jul 9;8:173. doi: 10.1186/1748-717X-8-173.

22.

Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer.

Goenka A, Morris LG, Rao SS, Wolden SL, Wong RJ, Kraus DH, Ohri N, Setton J, Lok BH, Riaz N, Mychalczak BR, Schoder H, Ganly I, Shah JP, Pfister DG, Zelefsky MJ, Lee NY.

Int J Cancer. 2013 Sep 1;133(5):1214-21. doi: 10.1002/ijc.28120. Epub 2013 Mar 29.

23.

Molecular pathways: understanding the role of Rad52 in homologous recombination for therapeutic advancement.

Lok BH, Powell SN.

Clin Cancer Res. 2012 Dec 1;18(23):6400-6. doi: 10.1158/1078-0432.CCR-11-3150. Epub 2012 Oct 15. Review.

24.

RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination.

Lok BH, Carley AC, Tchang B, Powell SN.

Oncogene. 2013 Jul 25;32(30):3552-8. doi: 10.1038/onc.2012.391. Epub 2012 Sep 10.

25.

Time course and predictors for cancer-related fatigue in a series of oropharyngeal cancer patients treated with chemoradiation therapy.

Spratt DE, Sakae M, Riaz N, Lok BH, Essandoh S, Hsu M, Zhang Z, Schupak K, Setton J, Lee NY.

Oncologist. 2012;17(4):569-76. doi: 10.1634/theoncologist.2011-0437. Epub 2012 Mar 7. Review.

26.

Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes.

Lok BH, Setton J, Caria N, Romanyshyn J, Wolden SL, Zelefsky MJ, Park J, Rowan N, Sherman EJ, Fury MG, Ho A, Pfister DG, Wong RJ, Shah JP, Kraus DH, Zhang Z, Schupak KD, Gelblum DY, Rao SD, Lee NY.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1851-7. doi: 10.1016/j.ijrobp.2011.03.029. Epub 2011 Jun 2.

27.

Impact of laparoscopic adjustable gastric banding on pregnancy, maternal weight, and neonatal health.

Carelli AM, Ren CJ, Youn HA, Friedman EB, Finger AE, Lok BH, Kurian MS, Fielding GA.

Obes Surg. 2011 Oct;21(10):1552-8. doi: 10.1007/s11695-010-0265-1.

PMID:
20835780
28.

Gastric banding with simultaneous panniculectomy: two case reports on technique.

Carelli AM, Rousou LJ, Lok BH, Marti JL, Fielding GA.

Surg Obes Relat Dis. 2009 Jul-Aug;5(4):507-9. doi: 10.1016/j.soard.2008.09.017. Epub 2008 Oct 9. No abstract available.

PMID:
19136314

Supplemental Content

Support Center